Company Filing History:
1 out of 297 
1 out of 832,761 Years Active: 2000-2002
Title: Charles L Densmore, Jr: Innovator in Liposomal Aerosol Composition
Introduction
Charles L Densmore, Jr. is an accomplished inventor based in The Woodlands, TX (US). He holds 2 patents that focus on advancements in lipid:DNA formulations, particularly in the context of nebulization. His work has significant implications for pharmaceutical applications and gene therapy.
Latest Patents
Densmore's latest patents include innovative formulations that enhance the stability of lipid:DNA compositions during nebulization. One of his notable inventions is a liposomal aerosol composition that comprises a pharmaceutical compound, a cationic lipid, a neutral co-lipid, and tryptone. This invention also features a nebulized cationic lipid:neutral co-lipid:DNA suspension that is useful for lipid-DNA transfections, utilizing bis(guanidinium)-tren-cholesterol as the cationic lipid and dioleoylphosphatidylethanolamine (DOPE) as the neutral co-lipid.
Career Highlights
Throughout his career, Densmore has contributed to various research initiatives and has been associated with the Research Development Foundation. His work has been pivotal in advancing the field of lipid-based drug delivery systems.
Collaborations
Densmore has collaborated with notable professionals in his field, including J Vernon Knight and J Clifford Waldrep. These collaborations have enriched his research and contributed to the development of his patented technologies.
Conclusion
Charles L Densmore, Jr. is a significant figure in the realm of pharmaceutical innovations, particularly in the stabilization of lipid:DNA formulations. His contributions continue to influence advancements in drug delivery systems and gene therapy applications.